V12 SENTINEL ENGINE · AI MARKET ANALYSIS
Row
M
MNPRAI Stock Diagnostic Report

Monopar Therapeutics director Raymond Anderson sells $351,835 in stock

Raymond Anderson, a director of Monopar Therapeutics, sold shares valued at $351,835.

View Source Article ↗
AI CATALYST SCORE35 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+
ANALYSIS HISTORY

MNPR Analysis History (Last 30 Days)

Diagnosed AtTickerAI ScoreTier
2026-08-29 00:13:45MNPR35RowView Report →
2026-08-13 17:14:32MNPR40RowView Report →
2026-07-07 18:46:44MNPR20RowView Report →
View Full History for MNPR (Blueprint) →